xtandi
astellas pharma europe b.v. - enzalutamid - prostatične neoplazme - endokrini terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
etonogestrel/etinilestradiol mithra pharmaceuticals 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem
etinilestradiol; etinilestradiol; etonogestrel - vaginalni dostavni sistem - etinilestradiol 2,7 mg / 1 sistem etinilestradiol2,7 mg / 1 sistem etonogestrel11,7 mg / 1 sistem; etinilestradiol 2,7 mg / 1 sistem etonogestrel11,7 mg / 1 sistem; etonogestrel 11,7 mg / 1 sistem - vaginalni obroček s progestogenom in estrogenom
revasc
canyon pharmaceuticals ltd. - desirudin - venska tromboza - antitrombotična sredstva - preprečevanje globoke venske tromboze pri bolnikih, ki so v postopku izbirnega kirurškega substitucijskega kolka ali kolena.
ztalmy
marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - drugi antiepileptics - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.
replagal
takeda pharmaceuticals international ag ireland branch - agalsidaza alfa - fabryjeva bolezen - drugi zdravljene bolezni prebavil in presnove izdelki, - replagal je indiciran za dolgoročno encimsko nadomestno zdravljenje pri bolnikih s potrjeno diagnozo fabryjeve bolezni (pomanjkanje α-galaktozidaze-a).
zolacitor 4 mg/5 ml koncentrat za raztopino za infundiranje
chiesi pharmaceuticals gmbh - zoledronska kislina - koncentrat za raztopino za infundiranje - zoledronska kislina 0,8 mg / 1 ml - zoledronska kislina
zolacitor 4 mg/5 ml koncentrat za raztopino za infundiranje
chiesi pharmaceuticals gmbh - zoledronska kislina - koncentrat za raztopino za infundiranje - zoledronska kislina 0,8 mg / 1 ml - zoledronska kislina
fentanil torrex 50 mikrogramov/ml raztopina za injiciranje
chiesi pharmaceuticals gmbh - fentanil - raztopina za injiciranje - fentanil 50 µg / 1 ml - fentanil
fentanil torrex 50 mikrogramov/ml raztopina za injiciranje
chiesi pharmaceuticals gmbh - fentanil - raztopina za injiciranje - fentanil 50 µg / 1 ml - fentanil
foster 200 mikrogramov/6 mikrogramov na sprožitev inhalacijska raztopina pod tlakom
chiesi pharmaceuticals gmbh - beklometazondipropionat; formoterolijev fumarat dihidrat - inhalacijska raztopina pod tlakom - beklometazondipropionat 200 µg / 1 odmerek formoterolijev fumarat dihidrat6 µg / 1 odmerek; formoterolijev fumarat dihidrat 6 µg / 1 odmerek - formoterol in beklometazon